117 related articles for article (PubMed ID: 25630683)
21. Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren.
Bandhuvula P; Saba JD
Trends Mol Med; 2007 May; 13(5):210-7. PubMed ID: 17416206
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of sphingosine-1-phosphate receptor 3 does not affect the skeletal phenotype of mice lacking sphingosine-1-phosphate lyase.
Heckt T; Brylka LJ; Neven M; Amling M; Schinke T
PLoS One; 2019; 14(7):e0219734. PubMed ID: 31314788
[TBL] [Abstract][Full Text] [Related]
23. Sphingosine 1-phosphate (S1P) lyase deficiency increases sphingolipid formation via recycling at the expense of de novo biosynthesis in neurons.
Hagen-Euteneuer N; Lütjohann D; Park H; Merrill AH; van Echten-Deckert G
J Biol Chem; 2012 Mar; 287(12):9128-36. PubMed ID: 22291021
[TBL] [Abstract][Full Text] [Related]
24. S1PR3 agonism and S1P lyase inhibition rescue mice in the severe state of experimental sepsis.
Ziegler AC; Haider RS; Hoffmann C; Gräler MH
Biomed Pharmacother; 2024 May; 174():116575. PubMed ID: 38599060
[TBL] [Abstract][Full Text] [Related]
25. Pharmacology of the sphingosine-1-phosphate signalling system.
Zu Heringdorf DM; Ihlefeld K; Pfeilschifter J
Handb Exp Pharmacol; 2013; (215):239-53. PubMed ID: 23579459
[TBL] [Abstract][Full Text] [Related]
26. S1P lyase inhibition protects against sepsis by promoting disease tolerance via the S1P/S1PR3 axis.
Weigel C; Hüttner SS; Ludwig K; Krieg N; Hofmann S; Schröder NH; Robbe L; Kluge S; Nierhaus A; Winkler MS; Rubio I; von Maltzahn J; Spiegel S; Gräler MH
EBioMedicine; 2020 Aug; 58():102898. PubMed ID: 32711251
[TBL] [Abstract][Full Text] [Related]
27. Regulation of cell death by sphingosine 1-phosphate lyase.
Colié S; Codogno P; Levade T; Andrieu-Abadie N
Autophagy; 2010 Apr; 6(3):426-7. PubMed ID: 20215862
[TBL] [Abstract][Full Text] [Related]
28. Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.
Meyer-Schwesinger C; Dehde S; Sachs M; Mathey S; Arefi K; Gatzemeier S; Balabanov S; Becker JU; Thaiss F; Meyer TN
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1015-25. PubMed ID: 22811486
[TBL] [Abstract][Full Text] [Related]
29. A facile stable-isotope dilution method for determination of sphingosine phosphate lyase activity.
Suh JH; Eltanawy A; Rangan A; Saba JD
Chem Phys Lipids; 2016 Jan; 194():101-9. PubMed ID: 26408264
[TBL] [Abstract][Full Text] [Related]
30. Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency.
Lovric S; Goncalves S; Gee HY; Oskouian B; Srinivas H; Choi WI; Shril S; Ashraf S; Tan W; Rao J; Airik M; Schapiro D; Braun DA; Sadowski CE; Widmeier E; Jobst-Schwan T; Schmidt JM; Girik V; Capitani G; Suh JH; Lachaussée N; Arrondel C; Patat J; Gribouval O; Furlano M; Boyer O; Schmitt A; Vuiblet V; Hashmi S; Wilcken R; Bernier FP; Innes AM; Parboosingh JS; Lamont RE; Midgley JP; Wright N; Majewski J; Zenker M; Schaefer F; Kuss N; Greil J; Giese T; Schwarz K; Catheline V; Schanze D; Franke I; Sznajer Y; Truant AS; Adams B; Désir J; Biemann R; Pei Y; Ars E; Lloberas N; Madrid A; Dharnidharka VR; Connolly AM; Willing MC; Cooper MA; Lifton RP; Simons M; Riezman H; Antignac C; Saba JD; Hildebrandt F
J Clin Invest; 2017 Mar; 127(3):912-928. PubMed ID: 28165339
[TBL] [Abstract][Full Text] [Related]
31. Sphingosine 1-phosphate lyase ablation disrupts presynaptic architecture and function via an ubiquitin- proteasome mediated mechanism.
Mitroi DN; Deutschmann AU; Raucamp M; Karunakaran I; Glebov K; Hans M; Walter J; Saba J; Gräler M; Ehninger D; Sopova E; Shupliakov O; Swandulla D; van Echten-Deckert G
Sci Rep; 2016 Nov; 6():37064. PubMed ID: 27883090
[TBL] [Abstract][Full Text] [Related]
32. Sphingosine-1-phosphate lyase (SGPL1) deficiency is associated with mitochondrial dysfunction.
Maharaj A; Williams J; Bradshaw T; Güran T; Braslavsky D; Casas J; Chan LF; Metherell LA; Prasad R
J Steroid Biochem Mol Biol; 2020 Sep; 202():105730. PubMed ID: 32682944
[TBL] [Abstract][Full Text] [Related]
33. Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism.
Bourquin F; Riezman H; Capitani G; Grütter MG
Structure; 2010 Aug; 18(8):1054-65. PubMed ID: 20696404
[TBL] [Abstract][Full Text] [Related]
34. A high-throughput scintillation proximity assay for sphingosine-1-phosphate lyase.
Kashem MA; Wa C; Wolak JP; Grafos NS; Ryan KR; Sanville-Ross ML; Fogarty KE; Rybina IV; Shoultz A; Molinaro T; Desai SN; Rajan A; Huber JD; Nelson RM
Assay Drug Dev Technol; 2014 Jun; 12(5):293-302. PubMed ID: 24846303
[TBL] [Abstract][Full Text] [Related]
35. Scintillation Proximity Assay to Detect the Changes in Cellular Dihydrosphingosine 1-Phosphate Levels.
Ohtoyo M; Tamura M; Machinaga N; Muro F; Hashimoto R
Lipids; 2016 Oct; 51(10):1207-1216. PubMed ID: 27585475
[TBL] [Abstract][Full Text] [Related]
36. Cellular assay for the characterization of sphingosine-1-phosphate lyase inhibitors.
Billich A; Beerli C; Bergmann R; Bruns C; Loetscher E
Anal Biochem; 2013 Mar; 434(2):247-53. PubMed ID: 23246729
[TBL] [Abstract][Full Text] [Related]
37. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.
Schwalm S; Pfeilschifter J; Huwiler A
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):44-9. PubMed ID: 23789924
[TBL] [Abstract][Full Text] [Related]
38. Discontinued postnatal thymocyte development in sphingosine 1-phosphate-lyase-deficient mice.
Weber C; Krueger A; Münk A; Bode C; Van Veldhoven PP; Gräler MH
J Immunol; 2009 Oct; 183(7):4292-301. PubMed ID: 19748984
[TBL] [Abstract][Full Text] [Related]
39. The first sphingosine 1-phosphate lyase inhibitors against multiple sclerosis: a successful drug discovery tale.
Cosconati S; Novellino E
J Med Chem; 2014 Jun; 57(12):5072-3. PubMed ID: 24913310
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932).
Bagdanoff JT; Donoviel MS; Nouraldeen A; Carlsen M; Jessop TC; Tarver J; Aleem S; Dong L; Zhang H; Boteju L; Hazelwood J; Yan J; Bednarz M; Layek S; Owusu IB; Gopinathan S; Moran L; Lai Z; Kramer J; Kimball SD; Yalamanchili P; Heydorn WE; Frazier KS; Brooks B; Brown P; Wilson A; Sonnenburg WK; Main A; Carson KG; Oravecz T; Augeri DJ
J Med Chem; 2010 Dec; 53(24):8650-62. PubMed ID: 21090716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
